In 2023, the sold production of medicaments containing hormones but not antibiotics for therapeutic or prophylactic uses in Italy stood at 30.075 million euros. The forecasted data shows a steady upward trend from 2024 to 2028, starting at 30.251 million euros in 2024 and reaching 30.956 million euros in 2028. This indicates consistent growth with an average compound annual growth rate (CAGR) over these forecasted years.

Future trends to watch for include:

Monitoring the impact of regulatory changes on production and sales.
Considering potential advancements in pharmaceutical technologies that could affect production costs and methods.
Assessing the influence of global market conditions on local production in Italy.